SHWSherwin-Williams

$319.37-8.0% 1Y

$319.37

$293.0052 weeks$370.82

Is the price fair?

Fair

Neither cheap nor expensive: nothing decisive, though priced for +8% a year vs +2% a year delivered.

1 to watch, 1 neutral, 1 without data

What the price assumes~+8% a yearderived · Jun 30, 2026

Priced for ~8% a year FCF growth. The price demands more than its three-year revenue growth of 2% a year, priced for acceleration.

Vs its own P/E rangemid-range for this companyderived

In its normal range: P/E 29.4 vs a 30.7 median over 41 quarters (−4% vs median).

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

P/E (valuation)behind 67% of the market

FCF yieldmiddle of the market

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

Sherwin-Williams trades at 29.4× earnings against 29.4× for the median Specialty Chemicals name, cheaper than its own group.

29.4

Trailing P/E · Specialty Chemicals median 29.4 · cheaper than the typical name in its group

Price / sales: 3.24
Price / sales · today's price, trailing year to Jun 30, 2026
Free cash flow yield: 4.1%
Free cash flow yield · Specialty Chemicals median 4.7%
Growth the price implies: +8.4%
Growth the price implies · The price pays for +8.4% free cash flow growth a year for a decade; the business has delivered +22% a year over the last three.

Details›

What the market has paid for these earnings: 41 quarters of its own multiple × $10.85 of trailing earnings per share
Method	Per share
Its own P/E history, lower quartile	$289.85
Its own P/E history, median	$333.13
Its own P/E history, upper quartile	$362.72
52-week range	$293.00 – $370.82
Today	$319.37

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.

The closest names by size in the same industry